Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Stevens

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Astrobiology|January 30, 2018
The UK Centre for Astrobiology: A Virtual Astrobiology Centre. Accomplishments and Lessons Learned, 2011-2016Charles S Cockell, Beth Biller, Casey Bryce, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2016
mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic SuccessMarie Szymanowski, Maria Salomon Estebanez, Raja Padidela, et al.
Diabetes|May 2, 2015
Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-ChannelRachel J Salisbury, Bing Han, Rachel E Jennings, et al.
The Pharmacogenomics Journal|May 28, 2021
Gene expression signatures predict response to therapy with growth hormoneAdam Stevens, Philip Murray, Chiara De Leonibus, et al.
Cell Death & Disease|October 21, 2020
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewalRoberto Paredes, James R Kelly, Bethany Geary, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Nucleic Acids Research|June 26, 2018
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cell Death & Disease|June 16, 2017
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruptionStefan Meyer, Adam Stevens, Roberto Paredes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2020
A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 24, 2020
Correction: A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Astrobiology|January 30, 2018
The UK Centre for Astrobiology: A Virtual Astrobiology Centre. Accomplishments and Lessons Learned, 2011-2016Charles S Cockell, Beth Biller, Casey Bryce, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2016
mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic SuccessMarie Szymanowski, Maria Salomon Estebanez, Raja Padidela, et al.
Diabetes|May 2, 2015
Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-ChannelRachel J Salisbury, Bing Han, Rachel E Jennings, et al.
The Pharmacogenomics Journal|May 28, 2021
Gene expression signatures predict response to therapy with growth hormoneAdam Stevens, Philip Murray, Chiara De Leonibus, et al.
Cell Death & Disease|October 21, 2020
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewalRoberto Paredes, James R Kelly, Bethany Geary, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Nucleic Acids Research|June 26, 2018
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cell Death & Disease|June 16, 2017
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruptionStefan Meyer, Adam Stevens, Roberto Paredes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2020
A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 24, 2020
Correction: A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Pageof 8